
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
On March 15, 2023, Dr. Paul Offit, Director of the VEC, discussed “The Future of COVID-19 Vaccines.” Free continuing education credits (CME, CEU, CPE) are available thanks to support from the Thomas F. McNair Scott Endowed Research and Lectureship Fund. The Vaccine Education Center (VEC) at Children’s Hospital of Philadelphia would also like to thank our co-sponsors, the Pennsylvania chapter of the American Academy of Pediatrics and Nesbitt School of Pharmacy at Wilkes University.






